Current Concepts in axSpA

Activity Overview and Format

This program will educate learners through a self-directed approach. The program is structured to provide education that will assist rheumatology and dermatology healthcare professionals (HCPs) who treat axial spondyloarthritis (axSpA) in evaluating recent evidence pertaining to the diagnosis, management, and treatment of axSpA. Each of the 8 modules will provide a comprehensive overview on a topic relevant to the diagnosis or management of axSpA and an expert discussion concerning application of the information presented to clinical practice.

The goals of this program are to better prepare HCPs to recognize axSpA, understand how to treat axSpA based on latest guideline recommendations, and know how to apply current evidence concerning biologic therapies.

Intended Audience and CME/CE Credits

This activity is intended for rheumatologists, dermatologists, and other rheumatology and dermatology HCPs who treat axSpA and related conditions.

3.5 AMA PRA Category 1 Credits^™

3.5 CE for Nurses/Nurse Practitioners

Learning Objectives

Upon completion of this activity, learners will be able to:

Access the latest data and information about the etiology, manifestations, comorbidities, and natural history of axSpA
Appropriately use and interpret clinical, laboratory, and imaging assessments to facilitate timely detection, diagnosis, and classification of axSpA
Apply contemporary evidence to the selection, surveillance, and management of current axSpA therapies
Evaluate emerging options for the treatment of axSpA and their potential role in reducing the burden of axSpA

Faculty

Atul Deodhar, MD, MRCP
Professor of Medicine, Division of Arthritis and Rheumatic Diseases, School of Medicine Medical Director, Rheumatology Clinics Oregon Health & Science University Portland, OR

Helena Marzo-Ortega, LMS, MRCP, PhD
Consultant Rheumatologist Honorary Clinical Associate Professor University of Leeds Leeds, United Kingdom